drugset / Trial / NCT01284114

Effects of Aliskiren in Elderly Hypertensive Chronic Kidney Disease (CKD) Patients

NCT01284114

Phase 4 Completed 23 enrolled Jichi Medical University
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether aliskiren is effective in the treatment of blood pressure, hear function, renal function in elderly hypertensive chronic kidney disease (CKD) patients.

Timeline

Start
2011-02
Primary completion
2012-05
Completion
2012-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aliskiren Small molecule 150 mg Oral
Comparator Aliskiren Small molecule 300 mg Oral